- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07839910
Wearable tDCS and Acute Golf Shot Performance
Acute Effects of Wearable Transcranial Direct Current Stimulation on Golf Shot Performance: a Randomized, Sham-controlled Trial
Transcranial direct current stimulation (tDCS) has been investigated as an ergogenic aid for two decades, but most sport evidence comes from laboratory stimulators operated by experimenters. This trial evaluates whether a single 20-minute session of wearable, app-controlled bilateral motor-cortex tDCS (Halo Sport 2, 2 mA) improves full-swing golf shot performance compared with sham stimulation. The study is a double-blind, sham-controlled, parallel-group randomized trial with a pre-test/post-test design in golfers stratified into professional, amateur-high, and amateur-middle skill groups. Each participant attends a single session comprising a 40-shot pre-test, 20 minutes of real or sham stimulation, and a 40-shot post-test, with shots measured by a TrackMan 4 launch monitor across eight standardized club categories. The primary outcomes are change scores (post minus pre) in carry distance, ball speed, smash factor, within-player carry-distance variability, and absolute lateral deviation. Effects will be examined overall and as a function of skill level (categorical group and continuous golf handicap).
Study Overview
Status
Intervention / Treatment
Detailed Description
Participants are stratified by skill level (professional, amateur-high, amateur-middle) and sex, and randomly assigned 1:1 to real or sham stimulation using a computer-generated sequence; allocation is concealed from the testing team. Real stimulation: Halo Sport 2 headset, bilateral primary motor cortex (approximately C3/C4), 2 mA for 20 minutes (30-s ramp up and down), controlled by smartphone app. Sham: identical device and app procedure with a 30-s current ramp-up followed immediately by ramp-down and no sustained current; the app does not display the stimulation mode. Each participant attends one session: 10-min standardized warm-up, 40-shot pre-test, 20-min stimulation, 40-shot post-test. Shot outcomes (carry distance, ball speed, smash factor, spin rate, launch angle, launch direction, club speed, attack angle, face-to-path) are recorded with a TrackMan 4 launch monitor; within-player variability (SD of five shots) is computed per club category (Driver, 3-wood, hybrid, 5-iron, 7-iron, 9-iron, 70-yd wedge task, 100-yd wedge task). Analyses use linear mixed models with likelihood-ratio tests; skill-dependent moderation is tested categorically (group) and continuously (handicap linear and quadratic interactions) with false-discovery-rate correction. Anonymized participant-level data and analysis scripts will be made available in a public repository (Zenodo, https://doi.org/10.5281/zenodo.22684611).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, China, 200438
- Shanghai University of Sport, School of Physical Education
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age ≥ 16 years;
- at least 2 years of systematic golf training;
- own set of clubs covering the standardized test clubs;
- right-handedness;
- normal or corrected-to-normal vision;
- no musculoskeletal injury in the previous 6 months that would affect the golf swing.
Exclusion Criteria:
- History of neurological or psychiatric disease; epilepsy;
- metal implants in the head; pregnancy;
- skin lesions under the electrode sites;
- current use of central-nervous-system-active medication;
- migraine within the previous year.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Real tDCS
Single 20-minute session of 2 mA transcranial direct current stimulation delivered by a wearable headset (Halo Sport 2, fixed configuration): anode 24 cm² at Cz, return electrodes 16 cm² at C5 and C6, 30-second ramp-up and ramp-down. Anode current density approximately 0.083 mA/cm². |
Participants stratified by skill group (professional / amateur-high / amateur-middle) and sex, then randomly assigned 1:1 to real or sham stimulation |
|
Sham Comparator: Sham tDCS
Identical headset and electrode placement with a 30-second ramp-up followed immediately by ramp-down, delivering no effective current. |
Participants stratified by skill group (professional / amateur-high / amateur-middle) and sex, then randomly assigned 1:1 to real or sham stimulation |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Carry distance change
Time Frame: Baseline and immediately after intervention (same-day single session)
|
Post minus pre carry distance (yards), per club category |
Baseline and immediately after intervention (same-day single session)
|
|
Ball speed change
Time Frame: Baseline and immediately after intervention (same-day single session)
|
Post minus pre ball speed (mph), per club category |
Baseline and immediately after intervention (same-day single session)
|
|
Smash factor change
Time Frame: Baseline and immediately after intervention (same-day single session)
|
Post minus pre smash factor (ball speed / club speed), per club category |
Baseline and immediately after intervention (same-day single session)
|
|
Carry distance variability change
Time Frame: Baseline and immediately after intervention (same-day single session)
|
Post minus pre within-player SD of the five shots per club category (yards) |
Baseline and immediately after intervention (same-day single session)
|
|
Absolute lateral deviation change
Time Frame: Baseline and immediately after intervention (same-day single session)
|
Post minus pre absolute carry-side deviation (yards), per club category | |
Baseline and immediately after intervention (same-day single session)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Total distance change
Time Frame: Baseline and immediately after intervention (same-day single session)
|
Baseline and immediately after intervention (same-day single session)
|
|
Spin rate change
Time Frame: Baseline and immediately after intervention (same-day single session)
|
Baseline and immediately after intervention (same-day single session)
|
|
Launch angle change
Time Frame: Baseline and immediately after intervention (same-day single session)
|
Baseline and immediately after intervention (same-day single session)
|
|
Absolute face-to-path change
Time Frame: Baseline and immediately after intervention (same-day single session)
|
Baseline and immediately after intervention (same-day single session)
|
|
Absolute launch direction change
Time Frame: Baseline and immediately after intervention (same-day single session)
|
Baseline and immediately after intervention (same-day single session)
|
|
Club head speed change
Time Frame: Baseline and immediately after intervention (same-day single session)
|
Baseline and immediately after intervention (same-day single session)
|
|
Attack angle change
Time Frame: Baseline and immediately after intervention (same-day single session)
|
Baseline and immediately after intervention (same-day single session)
|
|
Ball speed variability change(within-player SD of five shots)
Time Frame: Baseline and immediately after intervention (same-day single session)
|
Baseline and immediately after intervention (same-day single session)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 102772025RT109
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Anonymized participant-level dataset and analysis scripts
IPD Sharing Time Frame
Available now, indefinitely
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.